Reverse Takeover & Suspension of Trading

Valereum PLC
31 August 2023

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR")


Logo Description automatically generated

31st August 2023

Valereum Plc

("Valereum" or the "Company")

Reverse Takeover & Suspension of Trading

Valereum Plc, the Gibraltar technology group, refers to the announcement released earlier today relating to the acquisition of the Gibraltar Stock Exchange ("GSX") which, if fully approved and completed, would constitute a reverse takeover for the purposes of the AQSE Access Rulebook.

Accordingly, trading in the Company's shares has been suspended by the Aquis Exchange. This will continue until such time as the Company is able to publish an admission document in relation to the acquisition or confirms that the acquisition is no longer in contemplation.

The admission document will be drawn from existing business plans and budgets for both Valereum and the GSX and we will start work on this now so that it can be ready for a re-admission as soon as possible. This is likely to be early October.

The Directors of the Company accept responsibility for the contents of this announcement.






Valereum Plc

Richard Poulden, Chairman

Tel: +971 4584 6284


AQSE Corporate Adviser

First Sentinel Corporate Finance

Brian Stockbridge

Tel: +44 (0) 7876 888 011


Investor Relations

J&H Communications Limited

George Hudson

Tel: +44 (0)7803 603130


For more information, please visit the Company's website at

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
UK 100

Latest directors dealings